Purdue Pharma to market Transcept Pharma's Intermezzo in US
Tuesday, August 04, 2009 10:00 IST Stamford, Connecticut
Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. announced entry into an exclusive license and collaboration agreement to commercialize Intermezzo (zolpidem tartrate sublingual tablet) in the United States.
